Family guy, physician scientist and open water swimmer who enjoys being at the core of precision med. to improve clinical outcomes through molecular diagnostics
Joined June 2020
- Tweets98
- Following530
- Followers137
- Likes1.2K
Daniel Sumarriva retweeted
Today, we are thrilled to share the news that Palmetto GBA’s Molecular Diagnostic Services Program (MolDX) Program issued a positive coverage decision for the Pathlight MRD test.
Read more here sagadiagnostics.com/saga-dia…
Daniel Sumarriva retweeted
Incredibly Proud of the SAGA Diagnostics Medical Team at @ASCO GI26 - @DanielSumarriva
@SAGAdiagnostics
oncodaily.com/voices/asco-gi…
#Cancer #Medicine #Health #Oncology #OncoDaily #ASCOGI26
Daniel Sumarriva retweeted
Discussing Longitudinal ctDNA Surveillance at the Annual Best of Breast Conference - @DanielSumarriva
oncodaily.com/voices/daniel-…
#Cancer #Medicine #Health #Oncology #OncoDaily #BreastCancer #MedX #MedNews #MedEd
Daniel Sumarriva retweeted
Way to Kick Off @ASCO 2025 at the Giants of Cancer Dinner - @DanielSumarriva
oncodaily.com/blog/asco-2025…
#OncoDaily #Oncology #Cancer #Health #Medicine #MedTwitter #MedEd #MedOnc #MedNews #ASCO25 #ASCO2025 #GiantsOfCancer @CancerWorldmag
Daniel Sumarriva retweeted
📌15 Posts Not to Miss from the 3rd Day of @ASCO 2025
The ASCO Annual Meeting 2025 is officially underway in Chicago! Running from May 30 to June 3, this year’s meeting brings together oncologists, researchers, and advocates worldwide to share the latest breakthroughs in cancer care.
This year’s theme, “Driving Knowledge to Action: Building a Better Future,” sets the tone for what ASCO 2025 is all about, turning research into real impact for patients. Visit the link to dive into the science, and hear directly from the people shaping the future of cancer care: oncodaily.com/societies/asco…
@ASCOPres @fabiomoraesmd @pashtoonkasi @DanielSumarriva @VivekSubbiah @ICR_London @ArmandOrlandi @RoupenMD @Dr_ElvinaA @NehemiasGuevar5 @GlopesMd @nataliagandur
#OncoDaily #Oncology #Cancer #Health #Medicine #ASCO25 #ASCO2025
Daniel Sumarriva retweeted
Enjoying the beautiful view during this special night at the 2025 Giants of Cancer Care awards ceremony! #GiantsCC25
@kalantriShreyas @OncologyOdyssey @Arthur_Aung @Jani_Chinmay
@NehemiasGuevar5 @DanielSumarriva
Daniel Sumarriva retweeted
Prevalence and molecular correlates of acquired EGFR resistance mutations in NSCLC - @DanielSumarriva
@carisls @LuisRaezMD @StephenVLiu @HirvaMamdani @HosseinBorghaei @MNagasaka
oncodaily.com/science/daniel…
#OncoDaily #Oncology #Cancer #Health #Medicine #MedTwitter #MedEd #MedOnc #MedNews #NSCLC #EGFR
Daniel Sumarriva retweeted
Outstanding work by Heber Reyes and team on critical disparities in cancer care across Mexico - @DanielSumarriva
@ElysseBg
oncodaily.com/url/279168
#OncoDaily #Oncology #Cancer #Health #Medicine #CancerCare
Daniel Sumarriva retweeted
We are publishing EGFR resistant tumor data here after profiling more than 45,000 tumors, the documentation of the prevalence of resistance mutations (718,721,797 etc.) is very important however we need to increase awareness to repeat molecular profiling after TKI failure to have more accurate idea of the mechanisms of resistance, thanks to @carisls @DanielSumarriva @StephenVLiu @nievamd @HirvaMamdani @GlopesMd @HosseinBorghaei @HinaKhanMD @MNagasaka Mark Socinsky Tony Wozniak for the collaboration @IASLC @EGFRResisters @EgfrUk @EGFRSummit @egfr @EGFRmNSCLC @DFEGFRcenter @MCIStrong @mhshospital @FLASCO_ORG #lungcancer #lcsm
tandfonline.com/doi/full/10.…
Daniel Sumarriva retweeted
Grateful for the recent invitation from the SLACOM to present on the Molecular Revolution in Precision Medicine - @DanielSumarriva
@LGCW2024
oncodaily.com/blog/daniel-su…
#Medicine #MolecularRevolution #OncoDaily #Oncology #PrecisionMedicine #SLACOM #Cancer #Health #MedX #MedEd
Daniel Sumarriva retweeted
Caris Life Sciences is proud to announce that it has published more than 1,000 studies across peer-reviewed manuscripts, posters, and abstracts since 2015, in collaboration with its research partners. Learn more: ow.ly/KRj150UtRLQ
Daniel Sumarriva retweeted
MI Cancer Seek™ is now available for clinical ordering. The first and only simultaneous WES/WTS-based assay with CDx indications for adult and pediatric patients. Read more about MI Cancer Seek and view important product information. ow.ly/1bmP50Uy9nN
Daniel Sumarriva retweeted
MI Cancer Seek™ is now available. The first and only simultaneous WES/WTS-based assay with CDx indications for adult and pediatric patients. Read more
about MI Cancer Seek and view important product information. ow.ly/8ouu50UEral #precisionmedicine
Daniel Sumarriva retweeted
Caris announces a strategic collaboration with @OntadaOncology to drive next-gen therapeutic development and advance cancer care. Learn more:
ow.ly/AgFS50UHeLs
Daniel Sumarriva retweeted
MI Cancer Seek™, the first and only simultaneous WES/WTS-based assay with FDA-approved CDx indications for molecular profiling of solid tumors for both adult and pediatric patients. Read more about MI Cancer Seek and view important product information: ow.ly/uIQh50UIzfe
Daniel Sumarriva retweeted
Great collaboration with Amazon Web Services (@awscloud) to accelerate research and enhance patient care through efficient data processing.
aws.amazon.com/blogs/hpc/how…
Daniel Sumarriva retweeted
📢Highlights from ISLB 2024: Exploring the Future of Liquid Biopsy
The 6th Annual Congress of the International Society of Liquid Biopsy (ISLB) in Denver brought together over 300 global experts to discuss the latest innovations in liquid biopsy technology, focusing on its potential in cancer diagnosis, monitoring, and treatment.
@ChristianRolfo @DrYukselUrun @MariantoniaNac1 @BrunaPellini @DanielSumarriva @nnadiagee @ElJanLe @dr_omshree @RobertoBoreaMD @drgandara @RobertoBoreaMD @CarlosPedrazV @jberchuck @eleonora_nicolo @ChristianRolfo
Explore More about ISLB 2024 Congress:
oncodaily.com/insight/192366
#Cancer #ISLB2024 #OncoDaily #Oncology #MedEd #MedX #MedNews #Medicine
Daniel Sumarriva retweeted
Great speech by @nayibbukele!